Bentley, Anthony; Filipovic, Ivana; Gooch, Katherine; … - In: Health economics review 3 (2013) 18, pp. 1-12
congenital heart disease; £19,168 for infants with chronic lung disease; £3,845 for preterm infants < 29 wGA; £30,205 for preterm …, showing that palivizumab would be a cost-effective use of National Health Service resources. …